Home / Business and Economy / HealthEquity Stock Dives Despite Earnings Beat
HealthEquity Stock Dives Despite Earnings Beat
30 Aug
Summary
- HealthEquity's stock fell significantly despite strong quarterly financial results.
- The company's fiscal Q2 earnings and sales surpassed Wall Street expectations.
- Investors reacted negatively to a slightly raised sales forecast and reiterated earnings guidance.
HealthEquity (NASDAQ: HQY) saw its stock price decline by 8.6% this past week, reaching as much as a 12% drop from its previous closing price. This significant sell-off occurred despite the company announcing robust results for its fiscal second quarter, which concluded on July 31.
During the fiscal second quarter, HealthEquity reported non-GAAP earnings per share of $1.24 on revenues of $350.7 million. Both figures exceeded the consensus analyst forecasts, with earnings surpassing expectations by $0.05 per share and revenue coming in approximately $1.5 million higher. Sales saw a year-over-year increase of 7.6%, while adjusted earnings per share grew by roughly 15.7%.
Despite beating expectations, the company's financial outlook did not sufficiently impress investors. HealthEquity marginally increased its full-year revenue target to a range of $1.411 billion to $1.421 billion, a slight uptick from its prior guidance. However, this revised forecast was only marginally ahead of the average analyst estimate of $1.42 billion. The company also maintained its guidance for adjusted earnings per share between $4.66 and $4.73, which was in line with the average analyst estimate of $4.72.
